Literature DB >> 27212263

Delayed-onset rhabdomyolysis related to olanzapine: a case report.

Yen-Feng Lee1,2, Wei-Chung Mao2, Yueh-Ming Tai1,2, Hsin-An Chang2,3, Yu-Chen Kao2,4, San-Yuan Huang2, Nian-Sheng Tzeng2,3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27212263      PMCID： PMC4876419          DOI： 10.11622/smedj.2016094

Source DB:  PubMed          Journal:  Singapore Med J        ISSN： 0037-5675            Impact factor:   1.858


× No keyword cloud information.
  5 in total

1.  Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message?

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2000-06       Impact factor: 4.530

2.  Antihistamine-induced rhabdomyolysis.

Authors:  Uday Khosla; Kelly S Ruel; Daniel P Hunt
Journal:  South Med J       Date:  2003-10       Impact factor: 0.954

3.  Serum creatine kinase elevation as a possible complication of therapy with olanzapine.

Authors:  Evgeniy Perlov; Ludger Tebartz van Elst; Martin Czygan; Emanuel Bubl; Dieter Ebert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-22       Impact factor: 3.000

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Serum creatine kinase elevation associated with olanzapine treatment.

Authors:  Bhaskar Punukollu; Helen Rutherford
Journal:  BMJ Case Rep       Date:  2008-11-20
  5 in total
  1 in total

1.  SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?

Authors:  Josef Finsterer; Fulvio A Scorza
Journal:  Int J Infect Dis       Date:  2020-09-28       Impact factor: 3.623
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.